Bioblast Pharma Announces Sale of its Trehalose Clinical Development Programs to Seelos Therapeutics
19 Feb 2019 //
PRESS RELEASE
Seelos Therapeutics Completes Acquisition of Trehalose from Bioblast Pharma
19 Feb 2019 //
GLOBNEWSWIRE
Bioblast Pharma Collaborates to Evaluate Trehalose for Sanfilippo Syndrome
14 Feb 2019 //
NASDAQ